A246720 Stock Overview
Engages in the development of diagnosis solutions in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ASTA Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,770.00 |
| 52 Week High | ₩10,550.00 |
| 52 Week Low | ₩3,910.00 |
| Beta | 1.19 |
| 11 Month Change | 0.85% |
| 3 Month Change | -5.92% |
| 1 Year Change | -37.48% |
| 33 Year Change | -6.84% |
| 5 Year Change | -17.62% |
| Change since IPO | -62.14% |
Recent News & Updates
Shareholder Returns
| A246720 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 0.4% | 9.4% | 2.3% |
| 1Y | -37.5% | 12.3% | -3.8% |
Return vs Industry: A246720 underperformed the KR Medical Equipment industry which returned 12.3% over the past year.
Return vs Market: A246720 underperformed the KR Market which returned -3.8% over the past year.
Price Volatility
| A246720 volatility | |
|---|---|
| A246720 Average Weekly Movement | 7.0% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.4% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A246720 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A246720's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 29 | Eung-Jun Cho | www.astams.com |
ASTA Corporation engages in the development of diagnosis solutions in South Korea. The company offers microorganism identification systems, such as MicroIDSys and MicroIDSys Elite, which is used for applications in the areas of rapid diagnosis of infectious diseases, food hygiene management, agriculture and stockbreeding quarantines, and prevention of bio-terrorism. It also iprovides IDSys LT/RT, a MALDI-TOF mass spectrometry solution; NosIDSys, an economical diagnostic system used for diagnosis and prevention of rare incurable diseases, such as cancer and degenerative brain diseases; OASys, an laser desorption ionization time of flight mass spectrometer for OLED analysis and test; MALDI Plate, a disposable plate; and rapid enzyme digestion system.
ASTA Corporation Fundamentals Summary
| A246720 fundamental statistics | |
|---|---|
| Market cap | ₩64.72b |
| Earnings (TTM) | -₩2.88b |
| Revenue (TTM) | ₩3.39b |
19.1x
P/S Ratio-22.5x
P/E RatioIs A246720 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A246720 income statement (TTM) | |
|---|---|
| Revenue | ₩3.39b |
| Cost of Revenue | ₩1.87b |
| Gross Profit | ₩1.52b |
| Other Expenses | ₩4.40b |
| Earnings | -₩2.88b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -212.11 |
| Gross Margin | 44.91% |
| Net Profit Margin | -84.94% |
| Debt/Equity Ratio | 0% |
How did A246720 perform over the long term?
See historical performance and comparison